SLN Stock Summary and Trading Ideas (Silence Therapeutics PLC - American Depository Share | NASDAQ:SLN)

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Silence Therapeutics PLC - American Depository Share trades on the NASDAQ stock market under the symbol SLN.

As of August 28, 2026, SLN stock price declined to $13.42 with 515,588 million shares trading.

SLN has a beta of 1.39, meaning it tends to be more sensitive to market movements. SLN has a correlation of 0.04 to the broad based SPY ETF.

SLN has a market cap of $834.11 million. This is considered a Small Cap stock.

Last quarter Silence Therapeutics PLC - American Depository Share reported $0 in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.06.

In the last 3 years, SLN traded as high as $27.72 and as low as $1.97.

The top ETF exchange traded funds that SLN belongs to (by Net Assets): IBB, GWX, APIE, IBBQ, BIB.

SLN has outperformed the market in the last year with a return of +163.1%, while the SPY ETF gained +19.7%. In the last 3 month period, SLN beat the market returning +95.6%, while SPY returned +2.2%. However, in the most recent 2 weeks SLN has underperformed the stock market by returning -2.2%, while SPY returned -0.9%.

SLN support price is $12.72 and resistance is $14.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLN shares will trade within this expected range on the day.